Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
NCT01399515
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Retinitis Pigmentosa
Retinal Diseases
Eye Diseases
Eye Disease, Hereditary
Retinal Degeneration
Interventions
DRUG:
Valproic Acid
Sponsor
Seoul National University Hospital